← All organizations
Highest phase reached
Phase 4
First clinical trial
Feb 1, 1998First marketed drug
Feb 18, 1946First NDA
Feb 18, 1946Last known activity
Jul 27, 2021
Acquired by Pharmacia & Upjohn → Pharmacia → Pfizer on Jan 2, 1995
Timeline
1880s
- Jan 1, 1886
Upjohn— Founded
1990s
- Jul 31, 1992
amlodipine— Marketing Organization
- Aug 7, 1992
cefpodoxime— NDA Organization
- Jan 2, 1995
Pharmacia & Upjohn— Acquired By
2000s
- Apr 16, 2003
Pfizer— Now
Drugs by trial phase (15 distinct, 9 trials)
Phase 4 (2 own, 0 via acquisition)
Phase 3 (1 own, 0 via acquisition)
Phase 2 (7 own, 0 via acquisition)
Phase 1 (2 own, 0 via acquisition)
Other trials (3 own, 0 via acquisition)
Indications
Approved for
- Adrenal Hyperplasia, Congenital
- Alopecia
- Alopecia Areata
- Anxiety Disorders
- Arthritis, Rheumatoid
- Asthma
- Back Pain
- Breast Neoplasms
- Bronchitis, Chronic
- Chancroid
- Common Cold
- Community-Acquired Infections
- Cystitis
- Dermatitis, Atopic
- Diabetes, Gestational
- Diabetes Mellitus, Type 2
- Erectile Dysfunction
- Gonorrhea
- Granuloma Inguinale
- Headache
- Heart Defects, Congenital
- Hypersensitivity
- Hypertension
- Hypogonadism
- Labor, Obstetric
- Leukemia
- Leukemia, Lymphocytic, Chronic, B-Cell
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive
- Lymphoma, Non-Hodgkin
- Mastitis
- Maxillary Sinusitis
- Musculoskeletal Pain
- Mycobacterium tuberculosis
- Obesity
- Otitis Media
- Panic Disorder
- Peptic Ulcer
- Pharyngitis
- Plague
- Pneumonia
- Puberty, Delayed
- Spasm
- Staphylococcal Infections
- Staphylococcal Skin Infections
- Tonsillitis
- Toothache
- Tuberculosis
- Tularemia
- Urinary Tract Infections
Marketed drugs (31)
Recent trials (9)
- NCT05053126Lead sponsorPhase 4Jul 27, 2021
- NCT00000743CollaboratorPhase 1Nov 2, 1999
- NCT00001048CollaboratorPhase 2Nov 2, 1999
- NCT00000741CollaboratorPhase 3Nov 2, 1999
- NCT00000753CollaboratorPhase 1Nov 2, 1999
- NCT00000742CollaboratorPhase 1Nov 2, 1999
- NCT00000819CollaboratorPhase 2Nov 2, 1999
- NCT00000674CollaboratorN/ANov 2, 1999
- NCT00005626CollaboratorPhase 2Feb 1, 1998
Details
- Founded
- Kalamazoo, MI, US Jan 1, 1886
- First NDA
- Feb 18, 1946
- Last known activity
- Jul 27, 2021
Designations held
- Priority review